VYNDAMAX® 61mg

Tafamidis is a medication used to treat transthyretin amyloidosis (ATTR), a rare and progressive disease that affects the nervous system, heart, and other organs. It works by stabilizing the transthyretin protein, which prevents the formation of harmful amyloid fibrils. Tafamidis has been shown to slow down the progression of ATTR and improve quality of life for patients.

Studies have demonstrated the efficacy and safety of Tafamidis in both hereditary and wild-type ATTR. It has been found to reduce the risk of cardiovascular hospitalization and mortality, as well as improve neuropathy symptoms.